Recent News | Press Release

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025 9:16:39 AM

Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in it...

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 17, 2025 8:56:47 AM

Seeks to clarify that certain hearing implants are prosthetics and therefore not subject to the hear...

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 12, 2025 2:45:23 PM

Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Signifi...

Envoy Medical to Participate in the 37th Annual ROTH Conference

Mar 10, 2025 10:56:43 AM

White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ...

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 24, 2025 10:45:03 AM

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2025) - Envoy Medical®, Inc. (NASDAQ: COC...

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Dec 19, 2024 8:44:15 AM

Initial patient enrollment anticipated during first quarter of 2025 White Bear Lake, Minnesota--(New...

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Dec 16, 2024 11:09:09 AM

WHITE BEAR LAKE, Minnesota , Dec. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”...

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 14, 2024 11:36:36 AM

FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT code...

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 12, 2024 9:27:20 AM

Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough...

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 8, 2024 9:28:24 AM

WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”)...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Envoy Medical to Participate in the 37th Annual ROTH Conference

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Be the first to know!
Subscribe to news updates.

Sounding Board

Hearing Health and Earth Day: More Connections than You Might Think

Empowering the Experts: World Hearing Day 2025

The Heart-Hearing Connection: Understanding the Role of Anxiety During Heart Health Month

Solutions

Company

Legal